of 13’s reactive ketone functionality as the dimethyl acetal
(f14) finally enabled (Scheme 3) direct N-amination via
Scheme 1. Synthesis of Isatin 13
Scheme 3. Synthesis of Indazole 17
deprotonation with sodium hydride and quenching with
O-(diphenylphosphinyl)hydroxylamine (DppONH2)13 to af-
ford isatin derivative 15. Gratifyingly, treatment of 15 with
aqueous sulfuric acid then produced the desired indazole core
(16), which was most conveniently manipulated as its methyl
ester (17).
of a specific embodiment of synthon 5 was commenced
(Scheme 1). In anticipation of the regiospecific ortho-
lithiation reaction, it was necessary to protect the known
aniline derivative 9, accessible in two steps from com-
mercially available 2-chloro-5-methylphenol (7),8 with re-
giochemical realignment occurring via a benzyne interme-
diate.8c Thus, treatment of 9 with pivaloyl chloride yielded
protected amine 10. Subsequent reaction of 10 with 2.2 equiv
of n-butyllithium at 0 °C effected ortho-lithiation to produce
dianion 11, which, upon quenching with diethyl oxalate,
afforded 12 as a single regioisomer.9 Attempts to aminate
12, however, either directly10 or via diazotization/reduction11
met with failure. In the end, the only productive transforma-
tion that could be achieved was acidic cleavage of the
pivaloyl group and subsequent cyclization to isatin 13.
Conversion of 13 to the corresponding indazole via a
hydrolysis/diazotization/reduction protocol (Scheme 2) failed,
The final ring-forming transformation was accomplished
as shown in Scheme 4. Although a one-pot, double nucleo-
Scheme 4. Synthesis of 1
Scheme 2. Isatin-Indazole Transformation
philic displacement of dibromobutane by 17 was not suc-
cessful, monoalkylation of 17 afforded regioisomer 1814 in
good yield along with a small amount of both regioisomer
19 and double alkylation product 20. Subsequent heating of
18 in anhydrous methanol effected cyclization of the third
despite ample precedent.12 Subsequent attempts to aminate
13, either via diazotization/reduction or directly with an
electrophilic aminating reagent, also failed. But protection
(6) For the synthesis of some monocyclic analogues of nigellicine, see:
Schmidt, A.; Habeck, T.; Kindermann, M. K.; Nieger, M. J. Org. Chem.
2003, 68, 5977-5982.
(7) For a recent review see: Whisler, M. C.; MacNeil, S.; Snieckus, V.;
Beak, P. Angew. Chem., Int. Ed. 2004, 43, 2206-2225.
(8) (a) Akita, H.; Matsukura, H.; Oishi, T. Tetrahedron Lett. 1986, 27,
5397-5400. (b) Claudi F.; Giorgioni, J. G.; Di Stefano, A.; Abbracchio,
M. P.; Paoletti, A. M.; Balduinio. W. J. Med. Chem. 1992, 35, 4408-
4414. (c) Saari, W. S. (Merck), U.S. Patent 3671636, 1972; Chem. Abstr.
1972, 77, 88083.
(9) Regiochemistry confirmed by nOe difference spectra (see Supporting
Information).
(10) (a) Carpino, L. A. J. Am. Chem. Soc. 1960, 82, 3133-3135. (b)
Ragnarsson, U. Chem. Soc. ReV. 2001, 30, 205-213.
(11) Coleman, G. H. Org. Synth. 1964, I, 442-445.
(1) Chugai Pharmaceutical Co., Ltd., Japan, Japanese Patent 60004185,
1985; Chem. Abstr. 1985, 102, 220870.
(2) Atta-ur-Rahman; Malik, S.; He, C.; Clardy, J. Tetrahedron Lett. 1985,
26, 2759-2762.
(3) Liu, Y.; Yang, J.; Liu, Q. Chem. Pharm. Bull. 2004, 52, 454-455.
(4) Atta-ur-Rahman; Malik, S.; Hasan, S. S.; Choudhary, M. I.; Ni, C.
Z.; Clardy, J. Tetrahedron Lett. 1995, 36, 1993-1996.
(5) A SciFinder Scholar search leads to a Ph.D. thesis titled “The
Total Synthesis of Three Natural Products: Nigellicine, Nigellidine, and
Chilenone-A” (Guneratne, R. D., Cornell University, 1988), but the title is
misleading since the thesis does not describe the synthesis of 1 nor 3.
2450
Org. Lett., Vol. 7, No. 12, 2005